Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced that it will issue its full-year 2022 financial results on Thursday, March 30, 2023.
Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced that it will issue its full-year 2022 financial results on Thursday, March 30, 2023.